Universidad Autónoma del Estado de México, Facultad de Medicina, Laboratorio de Investigación en Microbiología Médica y Ambiental, Toluca, Mexico.
Laboratorio de Ecología Molecular, Departamento de Sistemas Biológicos, Universidad Autónoma Metropolitana-Xochimilco, Ciudad de México, Mexico.
Rev Inst Med Trop Sao Paulo. 2023 Apr 14;65:e31. doi: 10.1590/S1678-9946202365031. eCollection 2023.
Mycetoma is a neglected tropical disease (NTD) declared by the World Health Organization (WHO) in 2016. It is characterized by the progressive growth of nodules and granulomatous lesions on the legs, arms, and trunk. It is potentially disfiguring and causes disability or amputations in working-age people from marginalized areas. The causative agents can be fungi (eumycetoma) or actinobacteria (actinomycetoma), the latter being the most common in America and Asia. Nocardia brasiliensis is the most important causal agent of actinomycetoma in the Americas. Taxonomic problems have been reported when identifying this species, so this study aimed to detect the 16S rRNA gene variations in N. brasiliensis strains using an in silico enzymatic restriction technique. The study included strains from clinical cases of actinomycetoma in Mexico, isolated from humans and previously identified as N. brasiliensis by traditional methods. The strains were characterized microscopically and macroscopically, then subjected to DNA extraction and amplification of the 16S rRNA gene by PCR. The amplification products were sequenced, and consensus sequences were constructed and used for genetic identification and in silico restriction enzyme analysis with the New England BioLabs® NEBcutter program. All study strains were molecularly identified as N. brasiliensis; however, in silico restriction analysis detected a diversity in the restriction patterns that were finally grouped and subclassified into 7 ribotypes. This finding confirms the existence of subgroups within N. brasiliensis. The results support the need to consider N. brasiliensis as a complex species.
足菌肿是 2016 年世界卫生组织(WHO)宣布的一种被忽视的热带病(NTD)。它的特征是腿部、手臂和躯干上结节和肉芽肿病变的进行性生长。它具有潜在的毁容性,并导致边缘化地区的劳动年龄人群残疾或截肢。病原体可以是真菌(真足菌肿)或放线菌(放线菌肿),后者在美国和亚洲最为常见。巴西奴卡菌是美洲放线菌肿的最重要病原体。在鉴定该物种时,已经报道了分类学问题,因此本研究旨在使用计算机酶切限制技术检测巴西奴卡菌菌株的 16S rRNA 基因变异。该研究包括来自墨西哥放线菌肿临床病例的菌株,这些菌株从人和以前通过传统方法鉴定为巴西奴卡菌的菌株中分离出来。对菌株进行了显微镜和宏观特征分析,然后进行 DNA 提取和 16S rRNA 基因的 PCR 扩增。扩增产物进行测序,构建并使用共识序列进行遗传鉴定和 New England BioLabs®NEBcutter 程序的计算机酶切分析。所有研究菌株均通过分子鉴定为巴西奴卡菌;然而,计算机酶切分析检测到酶切模式的多样性,最终将其分组并细分为 7 种核糖型。这一发现证实了巴西奴卡菌内存在亚群。研究结果支持将巴西奴卡菌视为复杂物种的必要性。